Evidence map›Paper›PMID 27113535›Full record

ArticleScientific reports2016

Unique behavior of Trypanosoma cruzi mevalonate kinase: A conserved glycosomal enzyme involved in host cell invasion and signaling.

Éden Ramalho Ferreira, Eduardo Horjales, Alexis Bonfim-Melo, Cristian Cortez, Claudio Vieira da Silva, Michel De Groote, Tiago José Paschoal Sobreira, Mário Costa Cruz, Fabio Mitsuo Lima, Esteban Mauricio Cordero and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Metacyclogenesis as the Starting Point of Chagas Disease.International journal of molecular sciences · 2023
    Review
  5. A Review on the Immunological Response againstPathogens (Basel, Switzerland) · 2023
    Review
  6. Review
  7. Released Parasite-Derived Kinases as Novel Targets for Antiparasitic Therapies.Frontiers in cellular and infection microbiology · 2022
    Review
  8. Ablation of theFrontiers in cellular and infection microbiology · 2022
    Article
  9. Article
  10. All Roads Lead to Cytosol:Frontiers in cellular and infection microbiology · 2021
    Review
  11. Review
  12. Frontiers in cellular and infection microbiology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Molecular Characterization ofFrontiers in cellular and infection microbiology · 2018
    Article
  19. Amastigote Synapse: The Tricks ofFrontiers in microbiology · 2018
    Article
  20. Commentary: Systems Biology Approach to Model the Life Cycle ofFrontiers in cellular and infection microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Éden Ramalho FerreiraDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Eduardo HorjalesInstituto de Física, USP, São Carlos, São Carlos, SP, Brazil.
Alexis Bonfim-MeloDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Cristian CortezDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Claudio Vieira da SilvaInstituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil.
Michel De GrooteInstituto de Física, USP, São Carlos, São Carlos, SP, Brazil.
Tiago José Paschoal SobreiraLaboratório Nacional de Biociências, Campinas, SP, Brazil.
Mário Costa CruzDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Fabio Mitsuo LimaDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Esteban Mauricio CorderoDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Nobuko YoshidaDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
José Franco da SilveiraDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Renato Arruda MortaraDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Diana BahiaDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Universidade Federal de São Paulo · BRBrazilian Biosciences National Laboratory · BRUniversidade Federal de Minas Gerais · BRUniversidade Federal de Uberlândia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mevalonate kinase (MVK) is an essential enzyme acting in early steps of sterol isoprenoids biosynthesis, such as cholesterol in humans or ergosterol in trypanosomatids. MVK is conserved from bacteria to mammals, and localizes to glycosomes in trypanosomatids. During the course of T. cruzi MVK characterization, we found that, in addition to glycosomes, this enzyme may be secreted and modulate cell invasion. To evaluate the role of TcMVK in parasite-host cell interactions, TcMVK recombinant protein was produced and anti-TcMVK antibodies were raised in mice. TcMVK protein was detected in the supernatant of cultures of metacyclic trypomastigotes (MTs) and extracellular amastigotes (EAs) by Western blot analysis, confirming its secretion into extracellular medium. Recombinant TcMVK bound in a non-saturable dose-dependent manner to HeLa cells and positively modulated internalization of T. cruzi EAs but inhibited invasion by MTs. In HeLa cells, TcMVK induced phosphorylation of MAPK pathway components and proteins related to actin cytoskeleton modifications. We hypothesized that TcMVK is a bifunctional enzyme that in addition to playing a classical role in isoprenoid synthesis in glycosomes, it is secreted and may modulate host cell signaling required for T. cruzi invasion.

Indexed as

Signal TransductionActin CytoskeletonAmino Acid SequenceAnimalsAntibodies, HelminthDimerizationHeLa CellsHost-Parasite InteractionsHumansLife Cycle StagesMiceMicrobodiesMicroscopy, FluorescenceMitogen-Activated Protein KinasesMolecular Dynamics SimulationPhosphorylationAntibodies, Helminthmevalonate kinaseMitogen-Activated Protein KinasesPhosphotransferases (Alcohol Group Acceptor)Recombinant Proteins

Identifiers

PMID27113535
PMCPMC4845012
OpenAlexW2343052213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.